There was recently an article in the news about mice who were flown on the International Space Station who resisted the normal loss of muscle mass associated with weightlessness as a result of receiving a drug containing a new myostatin inhibitor. The mice not only resisted muscle loss, they...
Scholar Rock, a small startup located in Cambridge, Massachusetts, revealed new data regarding lead drug candidate SRK-015 last week at the European Molecular Biology Organization’s annual meeting.
The compound is a “niche modulator inhibiting activation of the latent myostatin precursor,”...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.